Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.In trading on Thursday, shares of RDA Microelectronics Inc ( RDA) entered into oversold territory, hitting an RSI reading of 28.8, after changing hands as low as $17.58 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 64.7. A bullish investor could look at RDA's 28.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of RDA shares: Looking at the chart above, RDA's low point in its 52 week range is $9.05 per share, with $18.40 as the 52 week high point — that compares with a last trade of $17.80.
More from Stocks
U.S. Bancorp Beats Q3 Earnings Forecast as Loan, Mortgage Growth Drives Gains
U.S. Bancorp posted better-than-expected third quarter earnings Wednesday as loan and deposit growth, as well as robust mortgage activity, offset a low interest rate environment for the Minneapolis-based lender.
Park-Ohio Holdings: An Under-the-Radar Opportunity
The diversified manufacturing and supply chain management company holds big upside potential based on expectations of earnings ahead.
Forget Official Data, What Is Chinese Data Really Saying?
Capital outflows are twice as large today as they were the last time China devalued.
Netflix, Bank of America, Opioid Settlement, Brexit, MGM- 5 Things You Must Know
U.S. stock futures decline as Wall Street awaits another round of third-quarter earnings reports and global stocks trade mixed as investors monitored Brexit developments; Netflix, IBM and Bank of America report earnings Wednesday; McKesson, AmerisourceBergen and Cardinal Health reportedly are in talks to pay $18 billion to settle thousands of opioid-related lawsuits.